Stryker SYK Trauma and Extremities — Net Sales

Other product segments

Similar metrics at other companies

POS

POSTNut butters — Net Sales

$101.3M+392%

POS

POSTPet Food — Net Sales

$346.7M-19.9%

MDLNLaboratory and Diagnostics — Net Sales

$293M+0.7%

LCIIFurniture and mattresses — Net Sales

$136.76M+20.8%

LCIIWindows and doors — Net Sales

$235.56M+2.6%

TNCParts and consumables — Net Sales

$64.6M-4.0%

FAQ

What is Stryker's trauma and extremities — net sales?

Stryker (SYK) reported trauma and extremities — net sales of $1.04B in Q1 2026.

How has Stryker's trauma and extremities — net sales changed year-over-year?

Stryker's trauma and extremities — net sales increased by 9.5% year-over-year, from $945M to $1.04B.

What is the long-term trend for Stryker's trauma and extremities — net sales?

Over 4 years (2021 to 2025), Stryker's trauma and extremities — net sales has grown at a 10.3% compound annual growth rate (CAGR), from $2.66B to $3.95B.

What does trauma and extremities — net sales mean?

This metric represents the total revenue generated from the sale of medical devices and implants specifically designed for the treatment of bone fractures and orthopedic conditions affecting the extremities, such as hands, feet, and shoulders. It reflects the commercial performance of a specialized product portfolio that supports surgical interventions in trauma centers and orthopedic clinics. This segment is a critical driver of growth within the broader medical technology and reconstructive implant market.